DK1553929T3 - Sammensætning med kontrolleret frigivelse. - Google Patents

Sammensætning med kontrolleret frigivelse.

Info

Publication number: DK1553929T3
Authority: DK; Denmark
Prior art keywords: controlled release; release composition; composition; controlled; release
Prior art date: 2002-10-16

Application number

DK03754116.6T

Other languages

English (en)

Inventor

Yohko Akiyama

Takashi Kurasawa

Hiroto Bando

Naoki Nagahara

Original Assignee

Takeda Pharmaceutical

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-16

Filing date

2003-10-15

Publication date

2013-05-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32109465&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1553929(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-10-15 Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical

2013-05-13 Application granted granted Critical

2013-05-13 Publication of DK1553929T3 publication Critical patent/DK1553929T3/da

Links

238000013270 controlled release Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK03754116.6T 2002-10-16 2003-10-15 Sammensætning med kontrolleret frigivelse. DK1553929T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2002301876		2002-10-16
JP2003066336		2003-03-12
PCT/JP2003/013155 WO2004035020A2 (en)	2002-10-16	2003-10-15	Controlled release preparation

Publications (1)

Publication Number	Publication Date
DK1553929T3 true DK1553929T3 (da)	2013-05-13

Family

ID=32109465

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK03754116.6T DK1553929T3 (da)	2002-10-16	2003-10-15	Sammensætning med kontrolleret frigivelse.

Country Status (27)

Country	Link
US (7)	US7790755B2 (da)
EP (3)	EP2283827B1 (da)
JP (2)	JP5330967B2 (da)
KR (3)	KR101061750B1 (da)
CN (1)	CN101884629B (da)
AR (1)	AR041562A1 (da)
AU (2)	AU2003272098B2 (da)
BR (2)	BRPI0315142B8 (da)
CA (2)	CA2737851C (da)
CR (2)	CR10284A (da)
CY (1)	CY1114599T1 (da)
DK (1)	DK1553929T3 (da)
ES (1)	ES2410812T5 (da)
IL (1)	IL167447A (da)
MA (1)	MA27456A1 (da)
MX (2)	MX337937B (da)
MY (2)	MY148805A (da)
NO (2)	NO342002B1 (da)
NZ (2)	NZ552592A (da)
OA (1)	OA13143A (da)
PE (3)	PE20090076A1 (da)
PL (2)	PL218177B1 (da)
PT (1)	PT1553929E (da)
SG (1)	SG164281A1 (da)
SI (1)	SI1553929T1 (da)
TW (2)	TWI347202B (da)
WO (1)	WO2004035020A2 (da)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8101209B2 (en) *	2001-10-09	2012-01-24	Flamel Technologies	Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
FR2830447B1 (fr) *	2001-10-09	2004-04-16	Flamel Tech Sa	Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
CA2480826C (fr)	2002-04-09	2012-02-07	Flamel Technologies	Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
CA2518780C (en)	2003-03-12	2014-05-13	Takeda Pharmaceutical Company Limited	Drug composition having active ingredient adhered at high concentration to spherical core
US8980322B2 (en)	2003-03-17	2015-03-17	Takeda Pharmaceutical Company Limited	Controlled release composition
TW200606163A (en)	2004-04-22	2006-02-16	Eisai Co Ltd	Imidazopyridine compound
US8461187B2 (en)	2004-06-16	2013-06-11	Takeda Pharmaceuticals U.S.A., Inc.	Multiple PPI dosage form
CA2599340C (en)	2005-02-25	2012-12-04	Takeda Pharmaceutical Company Limited	Method for producing granules
WO2006093353A1 (ja) *	2005-03-03	2006-09-08	Takeda Pharmaceutical Company Limited	放出制御組成物
US20070015782A1 (en)	2005-04-15	2007-01-18	Eisai Co., Ltd.	Benzimidazole compound
US9040564B2 (en)	2005-04-28	2015-05-26	Eisai R&D Management Co., Ltd.	Stabilized composition
EP1965841A1 (en) *	2005-12-28	2008-09-10	Basf Se	Process for production of a water-absorbing material
WO2007122478A2 (en) *	2006-04-20	2007-11-01	Themis Laboratories Private Limited	Multiple unit compositions
WO2008094877A2 (en) *	2007-01-30	2008-08-07	Drugtech Corporation	Compositions for oral delivery of pharmaceuticals
US8679541B2 (en)	2007-03-14	2014-03-25	Particle Dynamics International, Llc	Spatial arrangement of particles in a drinking device for oral delivery of pharmaceuticals
BRPI0810353A2 (pt) *	2007-05-08	2019-02-26	Dow Global Technologies Inc	composição de polímero dispersável em água e processo para produzir uma composição de polímero dispersável em água
SG185296A1 (en) *	2007-10-12	2012-11-29	Takeda Pharmaceuticals Usa Inc	Methods of treating gastrointestinal disorders independent of the intake of food
EP2573082A1 (en)	2007-12-31	2013-03-27	Takeda Pharmaceutical Company Limited	Crystalline solvated forms of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole
TWI441658B (zh) *	2008-03-11	2014-06-21	Takeda Pharmaceutical	口腔崩解固體製劑
TWI519322B (zh) *	2008-04-15	2016-02-01	愛戴爾製藥股份有限公司	包含弱鹼性藥物及控制釋放劑型之組合物
FR2938432B1 (fr) *	2008-11-14	2011-05-20	Debregeas Et Associes Pharma	Nouveau procede de preparation de granules de principes actifs, et granules tels qu'obtenus
AU2010321874A1 (en) *	2009-11-20	2012-06-21	Handa Pharmaceuticals, Llc	Oral formulation for dexlansoprazole
US20110189271A1 (en) *	2010-02-02	2011-08-04	Vishal Lad	Pharmaceutical formulations of acid-labile drugs
US8961917B2 (en)	2010-05-12	2015-02-24	Spectrum Pharmaceuticals, Inc.	Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
EP2570120B1 (en) *	2010-06-08	2017-10-25	Kobe Gakuin Educational Foundation	Coated particle and method for producing coated particle
SG186301A1 (en)	2010-06-16	2013-02-28	Takeda Pharmaceuticals Usa Inc	Novel modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
WO2012001705A2 (en)	2010-06-29	2012-01-05	Cadila Healthcare Limited	Pharmaceutical compositions of (r)-lansoprazole
US20120164233A1 (en)	2010-07-30	2012-06-28	Ranbaxy Laboratories Limited	Pulsatile release pharmaceutical formulation of dexlansoprazole
US20120201886A1 (en) *	2010-07-30	2012-08-09	Micro Labs Limited	Coated Extended Release Pharmaceutical Compositions Containing Paliperidone
AU2011352037A1 (en) *	2010-12-29	2013-08-01	Dr. Reddy's Laboratories Ltd.	Modified release benzimidazole formulations
US8691275B2 (en)	2011-01-28	2014-04-08	Zx Pharma, Llc	Controlled-release melatonin compositions and related methods
US9532952B2 (en)	2011-01-28	2017-01-03	Physician's Seal, LLC	Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
US8808736B2 (en)	2011-02-11	2014-08-19	Zx Pharma, Llc	Enteric coated multiparticulate controlled release peppermint oil composition and related methods
AU2012214553B2 (en)	2011-02-11	2015-07-09	Sociétés des Produits Nestlé S.A.	Multiparticulate L-menthol formulations and related methods
US8911780B2 (en)	2011-02-11	2014-12-16	Zx Pharma, Llc	Multiparticulate L-menthol formulations and related methods
WO2012111024A1 (en)	2011-02-18	2012-08-23	Suven Nishtaa Pharma Pvt Ltd	Pharmaceutical compositions of dexlansoprazole
AU2012326976B2 (en)	2011-10-21	2017-08-17	Takeda Pharmaceutical Company Limited	Sustained-release preparation
US20130209592A1 (en) *	2012-02-13	2013-08-15	Steven C. Denstman	Plant Extract Based Compositions and Methods For Treating Chronic Wounds
US20140330192A1 (en) *	2012-02-13	2014-11-06	The Ex Plant Company	Dressing for application to a wound or burn
ES2706152T3 (es)	2013-04-23	2019-03-27	Zx Pharma Llc	Composición entérica de múltiples partículas revestida con subrevestimiento proteico
KR20160081322A (ko)	2014-12-31	2016-07-08	삼아제약 주식회사	양성자 펌프 억제제를 유효성분으로 포함하며 방출이 제어된 약제학적 조성물
KR101907116B1 (ko) *	2016-07-25	2018-10-11	한미약품 주식회사	에스오메프라졸, 또는 약학적으로 허용 가능한 그의 염을 포함하는, pH-의존성 약물 방출 특성이 개선된 제형
CN107648231B (zh) *	2016-07-25	2021-07-16	江苏豪森药业集团有限公司	右兰索拉唑药物制剂
KR101877350B1 (ko) *	2016-10-28	2018-08-09	한미약품 주식회사	에스오메프라졸 함유 복합 캡슐제 및 그 제조방법
KR102727681B1 (ko)	2019-02-08	2024-11-07	주식회사유한양행	덱스란소프라졸 또는 이의 약학적으로 허용 가능한 염을 함유하는 안정한 경구투여용 약학 제제
CN111909044A (zh) *	2019-05-09	2020-11-10	南京爱德程医药科技有限公司	2-(烷基氨基)乙基苯甲酸酯类化合物的合成方法
TWI859242B (zh) *	2019-05-31	2024-10-21	美商戴納立製藥公司	嘧啶基胺基-吡唑化合物之修飾釋放調配物及治療方法
US11839622B1 (en)	2020-01-15	2023-12-12	Randall Lewarchik	Consumable nutraceutical composition
KR102471545B1 (ko)	2020-11-20	2022-11-29	서울대학교 산학협력단	덱스란소프라졸을 유효성분으로 포함하는 pH 의존성 타블렛-인-캡슐 복합제제 및 이의 제조방법
WO2022192623A1 (en) *	2021-03-11	2022-09-15	In The Bowl Animal Health, Inc.	Oral canine feed and methods for controlling flea infestations in a canine
JP2024511956A (ja) *	2021-03-11	2024-03-18	インザボウルアニマルヘルス，インコーポレーテッド	経口のイヌ科動物の飼料およびイヌ科動物におけるダニの侵入を制御する方法
KR102803742B1 (ko)	2022-07-25	2025-05-13	주식회사 와이에스생명과학	덱스란소프라졸 함유 정제
EP4356904A1 (en) *	2022-10-19	2024-04-24	Sanovel Ilac Sanayi Ve Ticaret A.S.	A capsule comprising lansoprazole
KR20250167303A (ko)	2024-05-22	2025-12-01	한국유나이티드제약 주식회사	약제학적 제제

Family Cites Families (121)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE416649B (sv)	1974-05-16	1981-01-26	Haessle Ab	Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE7804231L (sv)	1978-04-14	1979-10-15	Haessle Ab	Magsyrasekretionsmedel
US4649043A (en) *	1982-03-22	1987-03-10	Alza Corporation	Drug delivery system for delivering a plurality of tiny pills in the gastrointestinal tract
ZA854287B (en)	1984-06-16	1986-02-26	Byk Gulden Lomberg Chem Fab	Dialkoxypyridines,process for their preparation,their use and medicaments containing them
JPS6150978A (ja)	1984-08-16	1986-03-13	Takeda Chem Ind Ltd	ピリジン誘導体およびその製造法
KR890000387B1 (ko)	1984-09-24	1989-03-16	디 엎존 캄파니	2-(피리딜알켄술 피닐)벤즈 이미드아졸류의 n-치환 유도체의 제조방법
IL76839A (en)	1984-10-31	1988-08-31	Byk Gulden Lomberg Chem Fab	Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GB8507779D0 (en) *	1985-03-26	1985-05-01	Fujisawa Pharmaceutical Co	Drug carrier
GB8518301D0 (en) *	1985-07-19	1985-08-29	Fujisawa Pharmaceutical Co	Hydrodynamically explosive systems
SE8505112D0 (sv)	1985-10-29	1985-10-29	Haessle Ab	Novel pharmacological compounds
JPS62277322A (ja)	1986-02-13	1987-12-02	Takeda Chem Ind Ltd	安定化された腸溶性抗潰瘍固形組成物
CA1327010C (en)	1986-02-13	1994-02-15	Tadashi Makino	Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
US4794001A (en) *	1986-03-04	1988-12-27	American Home Products Corporation	Formulations providing three distinct releases
JPH07121859B2 (ja)	1986-03-18	1995-12-25	第一製薬株式会社	徐放性カプセル剤
GB2189698A (en) *	1986-04-30	1987-11-04	Haessle Ab	Coated omeprazole tablets
JPH0643426B2 (ja)	1986-07-25	1994-06-08	東京田辺製薬株式会社	イミダゾ〔４，５−ｂ〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
JPH0674272B2 (ja)	1986-11-13	1994-09-21	エーザイ株式会社	ピリジン誘導体及びそれを含有する潰瘍治療剤
US5026560A (en)	1987-01-29	1991-06-25	Takeda Chemical Industries, Ltd.	Spherical granules having core and their production
JPH0832625B2 (ja)	1987-01-29	1996-03-29	武田薬品工業株式会社	有核顆粒およびその製造法
JP2549119B2 (ja)	1987-05-30	1996-10-30	三省製薬株式会社	外用剤
JP2602518B2 (ja) *	1988-01-27	1997-04-23	エーザイ株式会社	被覆された胃酸分泌抑制剤含有組成物
DE3822095A1 (de) *	1988-06-30	1990-01-04	Klinge Co Chem Pharm Fab	Neue arzneimittelformulierung sowie verfahren zu deren herstellung
US4980172A (en) *	1989-05-12	1990-12-25	Fey Michael S	Anti-smoking oral composition
FR2655266B1 (fr)	1989-12-05	1992-04-03	Smith Kline French Lab	Compositions pharmaceutiques a base de cimetidine.
US4965269A (en)	1989-12-20	1990-10-23	Ab Hassle	Therapeutically active chloro substituted benzimidazoles
US5229131A (en) *	1990-02-05	1993-07-20	University Of Michigan	Pulsatile drug delivery system
US5264223A (en) *	1990-03-29	1993-11-23	Japan Elanco Company, Ltd.	Hard capsule for pharmaceutical drugs and method for producing the same
US5286497A (en) *	1991-05-20	1994-02-15	Carderm Capital L.P.	Diltiazem formulation
US5326570A (en) *	1991-07-23	1994-07-05	Pharmavene, Inc.	Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
DE69222006T2 (de)	1991-10-30	1998-01-22	Glaxo Group Ltd	Mehrschichtzusammensetzungen enthaltend Histamin- oder Serotonin- Antagonisten
US5229135A (en) *	1991-11-22	1993-07-20	Prographarm Laboratories	Sustained release diltiazem formulation
JP3140465B2 (ja)	1992-09-18	2001-03-05	山之内製薬株式会社	ハイドロゲル徐放性製剤
US5686105A (en)	1993-10-19	1997-11-11	The Procter & Gamble Company	Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US5656290A (en)	1993-02-26	1997-08-12	The Procter & Gamble Company	Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5914132A (en) *	1993-02-26	1999-06-22	The Procter & Gamble Company	Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US5651983A (en) *	1993-02-26	1997-07-29	The Procter & Gamble Company	Bisacodyl dosage form for colonic delivery
JPH072650A (ja) *	1993-06-18	1995-01-06	Tanabe Seiyaku Co Ltd	放出部位制御型製剤
SE9302395D0 (sv)	1993-07-09	1993-07-09	Ab Astra	New pharmaceutical formulation
EP0758244B2 (en) *	1994-05-06	2008-02-13	Pfizer Inc.	Controlled-release dosage forms of azithromycin
SE9402431D0 (sv)	1994-07-08	1994-07-08	Astra Ab	New tablet formulation
EE03305B1 (et)	1994-07-08	2000-12-15	Astra Aktiebolag	Paljuosaline tableteeritud annusvorm I
GB2290965A (en) *	1994-07-11	1996-01-17	Therapicon Srl	Multiple layer capsules for drugs
SE504459C2 (sv)	1994-07-15	1997-02-17	Astra Ab	Förfarande för framställning av substituerade sulfoxider
US5567441A (en) *	1995-03-24	1996-10-22	Andrx Pharmaceuticals Inc.	Diltiazem controlled release formulation
HRP960232A2 (en)	1995-07-03	1998-02-28	Astra Ab	A process for the optical purification of compounds
US5945124A (en)	1995-07-05	1999-08-31	Byk Gulden Chemische Fabrik Gmbh	Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
SG80553A1 (en) *	1995-07-20	2001-05-22	Tanabe Seiyaku Co	Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
US6207198B1 (en) *	1995-09-21	2001-03-27	Schwarz Pharma Ag	Composition containing an acid-labile omeprazole and process for its preparation
US5567144A (en) *	1995-10-05	1996-10-22	Desa International Inc.	Hot surface ignition controller for fuel oil burner
US5840737A (en) *	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
US6699885B2 (en) *	1996-01-04	2004-03-02	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and methods of using same
SE9600070D0 (sv)	1996-01-08	1996-01-08	Astra Ab	New oral pharmaceutical dosage forms
SE9600071D0 (sv)	1996-01-08	1996-01-08	Astra Ab	New oral formulation of two active ingredients I
SE9600072D0 (sv) *	1996-01-08	1996-01-08	Astra Ab	New oral formulation of two active ingredients II
JPH09188617A (ja) *	1996-01-08	1997-07-22	Pola Chem Ind Inc	徐放性医薬組成物
US6159501A (en)	1996-03-08	2000-12-12	Nycomed Danmark A/S	Modified release multiple-units dosage composition for release of opioid compounds
US6156340A (en) *	1996-03-29	2000-12-05	Duquesne University Of The Holy Ghost	Orally administrable time release drug containing products
SE9602442D0 (sv) *	1996-06-20	1996-06-20	Astra Ab	Administration of pharmaceuticals
US5972389A (en) *	1996-09-19	1999-10-26	Depomed, Inc.	Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
GB9620709D0 (en) *	1996-10-04	1996-11-20	Danbiosyst Uk	Colonic delivery of weak acid drugs
TW385306B (en)	1996-11-14	2000-03-21	Takeda Chemical Industries Ltd	Method for producing crystals of benzimidazole derivatives
JP3828648B2 (ja)	1996-11-14	2006-10-04	武田薬品工業株式会社	２−（２−ピリジルメチルスルフィニル）ベンズイミダゾール系化合物の結晶およびその製造法
EP0951278A2 (en)	1997-01-03	1999-10-27	ELAN CORPORATION, Plc	Sustained release cisapride mini-tablet formulation
US6162463A (en) *	1997-05-01	2000-12-19	Dov Pharmaceutical Inc	Extended release formulation of diltiazem hydrochloride
KR20010012402A (ko) *	1997-05-09	2001-02-15	세이지 파마슈티칼스, 인크.	안정한 약제학적 경구 투여형
DE19732903A1 (de) *	1997-07-30	1999-02-04	Falk Pharma Gmbh	Pellet-Formulierung zur Behandlung des Intestinaltraktes
US5885616A (en) *	1997-08-18	1999-03-23	Impax Pharmaceuticals, Inc.	Sustained release drug delivery system suitable for oral administration
DE19742711C1 (de) *	1997-09-26	1999-05-20	Intec Bielenberg Gmbh & Co Kg	Vorrichtung zum Aufbringen von Klebepunkten auf ein Substrat
KR100387245B1 (ko) *	1997-10-17	2003-08-19	일양약품주식회사	유산균의안정화를위한미세장용성코팅과립
US6096340A (en) *	1997-11-14	2000-08-01	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
US6210717B1 (en)	1997-12-12	2001-04-03	Samyang Corporation	Biodegradable mixed polymeric micelles for gene delivery
SE9704869D0 (sv)	1997-12-22	1997-12-22	Astra Ab	New pharmaceutical formulaton II
SE9704870D0 (sv) *	1997-12-22	1997-12-22	Astra Ab	New pharmaceutical formulation I
DE19801811B4 (de)	1998-01-19	2004-12-23	Stada Arzneimittel Ag	Pharmazeutische Zubereitung zur oralen Verabreichung
WO1999038513A1 (en)	1998-01-30	1999-08-05	Sepracor Inc.	R-lansoprazole compositions and methods
DK173431B1 (da) *	1998-03-20	2000-10-23	Gea Farmaceutisk Fabrik As	Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs
US5945123A (en)	1998-04-02	1999-08-31	K-V Pharmaceutical Company	Maximizing effectiveness of substances used to improve health and well being
US6372254B1 (en) *	1998-04-02	2002-04-16	Impax Pharmaceuticals Inc.	Press coated, pulsatile drug delivery system suitable for oral administration
WO1999051208A1 (en)	1998-04-03	1999-10-14	Bm Research A/S	Controlled release composition
CA2298823C (en)	1998-04-20	2011-06-07	Eisai Co., Ltd.	Stabilized composition comprising a benzimidazole type compound
DE19820529A1 (de) *	1998-05-08	1999-11-11	Lohmann Therapie Syst Lts	Wirkstoff enthaltende orale und mucosale Zubereitung mit steuerbarer Wirkstofffreisetzung und ihre Verwendung
DK2263660T3 (da) *	1998-05-18	2018-01-02	Takeda Pharmaceuticals Co	Oralt desintegrerende tabletter.
ZA9810765B (en) *	1998-05-28	1999-08-06	Ranbaxy Lab Ltd	Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole.
ATE291418T1 (de)	1998-07-28	2005-04-15	Takeda Pharmaceutical	Leicht zerfallende feste zubereitung
IT1301947B1 (it)	1998-07-28	2000-07-20	Chiesi Farma Spa	Formulazioni farmaceutiche di beclometasone dipropionato per iltrattamento di malattie infiammatorie croniche della mucosa
US6093734A (en)	1998-08-10	2000-07-25	Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin	Prodrugs of proton pump inhibitors
JP4988088B2 (ja)	1998-08-12	2012-08-01	ニコメッドゲゼルシャフトミットベシュレンクテルハフツング	ピリジン−２−イルメチルスルフィニル−１ｈ−ベンズイミダゾール、もしくはピリジン−２−イルメチルスルフィニル−１ｈ−ベンズイミダゾールの骨格を有する化合物、またはその薬学的に許容される塩の経口投与形組成物を固定的に組み合わせた組成物
JP2000119181A (ja)	1998-10-06	2000-04-25	Kureha Chem Ind Co Ltd	エスクレチン及びその誘導体の放出制御経口製剤
EP1126826B3 (en) *	1998-11-02	2019-05-15	Alkermes Pharma Ireland Limited	Multiparticulate modified release composition of methylphenidate
US6511678B2 (en) *	1998-12-18	2003-01-28	Abbott Laboratories	Controlled release formulation of divalproex sodium
TWI289557B (en)	1999-06-17	2007-11-11	Takeda Chemical Industries Ltd	A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
EP1064938A1 (en)	1999-06-28	2001-01-03	Sanofi-Synthelabo	Pharmaceutical dosage forms for controlled release producing at least a timed pulse
IL131508A (en)	1999-08-19	2006-12-10	David Cohen	Microencapsulated and controlled-release formulations of isoflavone from enriched fractions of soy and other plants
CA2380333A1 (en)	1999-08-26	2001-03-01	Christian Andina	Pharmaceutical formulations
ES2168043B1 (es)	1999-09-13	2003-04-01	Esteve Labor Dr	Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
CA2386277A1 (en)	1999-10-01	2001-04-12	Natco Pharma Limited	An improved pharmaceutical composition and a process for its preparation
GB9923436D0 (en)	1999-10-04	1999-12-08	American Home Prod	Pharmaceutical compositions
TR200201205T2 (tr)	1999-11-02	2002-08-21	Basillea Pharmaceutica Ag	N-ikame edilmiş karbamoiloksialkil-azolyum türevleri.
US6627223B2 (en)	2000-02-11	2003-09-30	Eurand Pharmaceuticals Ltd.	Timed pulsatile drug delivery systems
IT1318376B1 (it)	2000-03-07	2003-08-25	Pharmatec Internat S R L	Forme solide orali a rilascio controllato contenenti mesalazina comeprincipio attivo.
DE10013029A1 (de) *	2000-03-17	2001-09-20	Roehm Gmbh	Mehrschichtige Arzneiform für die Colonfreigabe
WO2001080824A2 (en)	2000-04-19	2001-11-01	Eurand America, Inc.	Dual mechanism timed release dosage forms for low dose drugs
KR100775802B1 (ko)	2000-04-28	2007-11-12	다케다 야쿠힌 고교 가부시키가이샤	광학 활성 술폭시드 유도체의 제조 방법
US6419954B1 (en)	2000-05-19	2002-07-16	Yamanouchi Pharmaceutical Co., Ltd.	Tablets and methods for modified release of hydrophilic and other active agents
US6306435B1 (en) *	2000-06-26	2001-10-23	Yung Shin Pharmaceutical Industrial Co. Ltd.	Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
TWI232761B (en) *	2000-07-01	2005-05-21	Pharmaceutical Ind Tech & Dev	Capsule preparation for oral administration and the preparation method thereof
IT1318625B1 (it) *	2000-07-14	2003-08-27	Roberto Valducci	Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente.
JP5412023B2 (ja)	2000-08-04	2014-02-12	武田薬品工業株式会社	ベンズイミダゾール化合物の塩およびその用途
US6500457B1 (en)	2000-08-14	2002-12-31	Peirce Management, Llc	Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
EP1315481B1 (de)	2000-08-29	2006-12-06	Mepha AG	Arzneimittel zur behandlung von darmerkrankungen
WO2002026210A2 (en) *	2000-09-29	2002-04-04	Geneva Pharmaceuticals Inc.	Proton pump inhibitor formulation
JP2002187890A (ja)	2000-10-12	2002-07-05	Takeda Chem Ind Ltd	ベンズイミダゾール化合物、その製造法およびその用途
CA2425363A1 (en)	2000-10-12	2003-04-10	Fumihiko Sato	Benzimidazole compounds, process for producing the same and use thereof
WO2002032427A1 (en)	2000-10-20	2002-04-25	Galephar M/F	Stable oral formulation containing benzimidazole derivative
SI20720A (sl) *	2000-11-20	2002-06-30	LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d.	Nov farmacevtski pripravek v obliki celuloznih kapsul uporaben za derivate benzimidazola
SK287902B6 (sk)	2001-01-31	2012-03-02	Evonik Rohm Gmbh	Multiparticulate drug form and method for the preparation thereof
ITMI20010220A1 (it)	2001-02-05	2002-08-05	Valpharma Sa	Formulazioni multiparticolate per somministrazione orale di sali di litio idonee per una somministrazione al giorno
ATE381924T1 (de) *	2001-09-21	2008-01-15	Egalet As	Feste dispersionen mit kontrollierter freisetzung von carvedilol
EP1437352A4 (en)	2001-09-25	2004-12-08	Takeda Chemical Industries Ltd	BENZIMIDAZOLE COMPOUND, METHOD FOR THE PRODUCTION AND USE THEREOF
WO2003103638A1 (en) *	2002-06-07	2003-12-18	Geneva Pharmaceuticals, Inc.	Stabilized pharmaceutical compositions containing benzimidazole compounds
CA2514879C (en)	2003-01-03	2014-09-16	Shire Laboratories Inc.	Two or more enteric materials to regulate drug release

2003
- 2003-10-07 MY MYPI20033821A patent/MY148805A/en unknown
- 2003-10-09 TW TW092128054A patent/TWI347202B/zh not_active IP Right Cessation
- 2003-10-09 AR ARP030103672A patent/AR041562A1/es not_active Application Discontinuation
- 2003-10-09 TW TW100111514A patent/TWI378794B/zh not_active IP Right Cessation
- 2003-10-10 PE PE2008001635A patent/PE20090076A1/es not_active Application Discontinuation
- 2003-10-10 PE PE2003001034A patent/PE20050102A1/es active IP Right Grant
- 2003-10-10 PE PE2011001026A patent/PE20110544A1/es not_active Application Discontinuation
- 2003-10-15 CA CA2737851A patent/CA2737851C/en not_active Expired - Lifetime
- 2003-10-15 US US10/531,069 patent/US7790755B2/en active Active
- 2003-10-15 CN CN2010101671537A patent/CN101884629B/zh not_active Expired - Lifetime
- 2003-10-15 EP EP10177696.1A patent/EP2283827B1/en not_active Expired - Lifetime
- 2003-10-15 PL PL389571A patent/PL218177B1/pl unknown
- 2003-10-15 KR KR1020057006572A patent/KR101061750B1/ko not_active Expired - Lifetime
- 2003-10-15 MX MX2011000852A patent/MX337937B/es unknown
- 2003-10-15 ES ES03754116.6T patent/ES2410812T5/es not_active Expired - Lifetime
- 2003-10-15 PT PT37541166T patent/PT1553929E/pt unknown
- 2003-10-15 EP EP03754116.6A patent/EP1553929B2/en not_active Expired - Lifetime
- 2003-10-15 PL PL376222A patent/PL219122B1/pl unknown
- 2003-10-15 SI SI200332270T patent/SI1553929T1/sl unknown
- 2003-10-15 DK DK03754116.6T patent/DK1553929T3/da active
- 2003-10-15 NZ NZ552592A patent/NZ552592A/en not_active IP Right Cessation
- 2003-10-15 AU AU2003272098A patent/AU2003272098B2/en not_active Expired
- 2003-10-15 NZ NZ539353A patent/NZ539353A/en not_active IP Right Cessation
- 2003-10-15 EP EP10177692.0A patent/EP2277510B1/en not_active Expired - Lifetime
- 2003-10-15 WO PCT/JP2003/013155 patent/WO2004035020A2/en not_active Ceased
- 2003-10-15 SG SG200702817-8A patent/SG164281A1/en unknown
- 2003-10-15 MX MXPA05003902A patent/MXPA05003902A/es active IP Right Grant
- 2003-10-15 BR BRPI0315142A patent/BRPI0315142B8/pt not_active IP Right Cessation
- 2003-10-15 KR KR1020127004477A patent/KR101401913B1/ko not_active Expired - Lifetime
- 2003-10-15 KR KR1020107026652A patent/KR20100132082A/ko not_active Ceased
- 2003-10-15 OA OA1200500107A patent/OA13143A/en unknown
- 2003-10-15 CA CA2499574A patent/CA2499574C/en not_active Expired - Lifetime
- 2003-10-15 BR BR122016030094A patent/BR122016030094B8/pt active IP Right Grant
2005
- 2005-03-15 IL IL167447A patent/IL167447A/en active IP Right Grant
- 2005-04-19 MA MA28229A patent/MA27456A1/fr unknown
- 2005-05-13 NO NO20052400A patent/NO342002B1/no not_active IP Right Cessation
2008
- 2008-09-12 CR CR10284A patent/CR10284A/es unknown
- 2008-11-24 MY MYPI20084749A patent/MY169471A/en unknown
2009
- 2009-11-20 JP JP2009265244A patent/JP5330967B2/ja not_active Expired - Lifetime
- 2009-11-27 AU AU2009243408A patent/AU2009243408B2/en not_active Expired
2010
- 2010-07-08 US US12/832,659 patent/US20100272798A1/en not_active Abandoned
- 2010-07-08 US US12/832,683 patent/US8722084B2/en not_active Expired - Lifetime
- 2010-07-19 US US12/839,054 patent/US8784885B2/en not_active Expired - Lifetime
2011
- 2011-06-29 CR CR20110373A patent/CR20110373A/es unknown
2013
- 2013-03-25 JP JP2013062667A patent/JP5746722B2/ja not_active Expired - Lifetime
- 2013-06-21 CY CY20131100508T patent/CY1114599T1/el unknown
2014
- 2014-03-06 US US14/199,334 patent/US20140186449A1/en not_active Abandoned
- 2014-03-06 US US14/199,308 patent/US20140186448A1/en not_active Abandoned
2015
- 2015-12-28 US US14/981,191 patent/US20160128945A1/en not_active Abandoned
2018
- 2018-01-17 NO NO20180072A patent/NO343175B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
SG164281A1 (en)	2010-09-29
EP2277510A2 (en)	2011-01-26
TW200502006A (en)	2005-01-16
EP2277510A3 (en)	2012-02-01
AU2009243408A1 (en)	2009-12-17
CA2737851C (en)	2013-04-30
CN101884629A (zh)	2010-11-17
EP1553929B2 (en)	2016-11-16
NO342002B1 (no)	2018-03-12
WO2004035020A2 (en)	2004-04-29
US20160128945A1 (en)	2016-05-12
CR20110373A (es)	2011-08-24
US7790755B2 (en)	2010-09-07
NO20052400L (no)	2005-05-13
PE20090076A1 (es)	2009-03-02
HK1080378A1 (en)	2006-04-28
KR101401913B1 (ko)	2014-05-30
CR10284A (es)	2008-10-17
CA2499574A1 (en)	2004-04-29
NO20180072A1 (no)	2005-05-13
MY148805A (en)	2013-05-31
TW201125563A (en)	2011-08-01
OA13143A (en)	2006-12-13
BR122016030094B1 (pt)	2020-06-23
AU2009243408B2 (en)	2012-01-19
AR041562A1 (es)	2005-05-18
EP2283827A1 (en)	2011-02-16
US20100285120A1 (en)	2010-11-11
JP2013155181A (ja)	2013-08-15
NZ539353A (en)	2007-07-27
JP2010077144A (ja)	2010-04-08
CA2737851A1 (en)	2004-04-29
SI1553929T1 (sl)	2013-07-31
US20140186449A1 (en)	2014-07-03
KR101061750B1 (ko)	2011-09-02
MY169471A (en)	2019-04-12
BR0315142A (pt)	2005-08-09
KR20100132082A (ko)	2010-12-16
MA27456A1 (fr)	2005-07-01
PL218177B1 (pl)	2014-10-31
TWI347202B (en)	2011-08-21
BRPI0315142B8 (pt)	2021-05-25
CY1114599T1 (el)	2016-10-05
PL219122B1 (pl)	2015-03-31
WO2004035020A3 (en)	2004-06-24
IL167447A (en)	2015-07-30
EP1553929A2 (en)	2005-07-20
KR20120034809A (ko)	2012-04-12
CN101884629B (zh)	2013-08-21
US8784885B2 (en)	2014-07-22
AU2003272098B2 (en)	2009-12-10
US20060013868A1 (en)	2006-01-19
US8722084B2 (en)	2014-05-13
EP1553929B1 (en)	2013-03-27
PE20050102A1 (es)	2005-04-05
US20100272798A1 (en)	2010-10-28
KR20050072108A (ko)	2005-07-08
NO343175B1 (no)	2018-11-26
US20140186448A1 (en)	2014-07-03
AU2003272098A1 (en)	2004-05-04
EP2277510B1 (en)	2018-12-26
US20100278911A1 (en)	2010-11-04
PE20110544A1 (es)	2011-08-25
ES2410812T3 (es)	2013-07-03
JP5330967B2 (ja)	2013-10-30
JP5746722B2 (ja)	2015-07-08
ES2410812T5 (es)	2017-05-12
MX337937B (es)	2016-03-29
TWI378794B (en)	2012-12-11
NZ552592A (en)	2007-06-29
EP2283827B1 (en)	2019-10-02
MXPA05003902A (es)	2005-06-22
CA2499574C (en)	2011-07-05
PL376222A1 (en)	2005-12-27
BR122016030094B8 (pt)	2021-05-25
BR0315142B1 (pt)	2018-01-09
PT1553929E (pt)	2013-04-23

Publication	Publication Date	Title
DK1553929T3 (da)	2013-05-13	Sammensætning med kontrolleret frigivelse.
NO20052635D0 (no)	2005-06-01	Kontrollert frigivelsesdepot formuleringer
IS7806A (is)	2005-04-18	Ónæmisvaldandi samsetning
NO20023672L (no)	2003-02-10	Sammensetninger for kontrollert frigivelse
DE10393374D2 (de)	2005-09-01	Zusammensetzung
FR2862654B1 (fr)	2006-02-10	Composition amylacee filmogene
NO20050132D0 (no)	2005-01-11	Vaksinesammensetning
EP1559433A4 (en)	2009-11-04	STABILIZED COMPOSITION
DK1561472T3 (da)	2013-11-11	Faststofsammensætning
BR0300119B1 (pt)	2013-04-09	composiÇço aquosa.
IS7582A (is)	2004-12-03	Hraðlosandi lyfjablanda
SE0500163L (sv)	2005-01-24	Sammansättning
NO20044188L (no)	2004-12-03	Kontrollerte frigjoringsdoseformer
NO20044337L (no)	2004-10-12	Faststoff-dispergeringspreparat
NO20051500D0 (no)	2005-03-21	Substituerte heterocyklylpyrimidiner.
EP1561467A4 (en)	2008-06-25	COMPOSITION FOR RECOVERING DAMAGED SKIN
ES1051506Y (es)	2002-12-01	Juguete de composicion.
DE50307407D1 (de)	2007-07-19	Strömungsbremse
ITTO20020747A1 (it)	2003-02-25	Composizione.
NO20044140D0 (no)	2004-09-29	New Composition
ES1051856Y (es)	2003-02-01	Burlete perfeccionado.
ITTO20020745A1 (it)	2003-02-25	Composizione.
DE50309974D1 (de)	2008-07-24	Löseeinheit
ES1050965Y (es)	2002-10-01	Decantador perfeccionado.
ES1053110Y (es)	2003-07-01	Loseta perfeccionada.